Projects

A Prospective Study Exploring Determinants of Response to Combination Levothyroxine–Liothyronine (LT4+LT3) Therapy versus Levothyroxine Monotherapy in Symptomatic Hypothyroid Patients with Normal TSH Levels”

Project Description

Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.

Project Duration

2026 - 2027

Project Lead

Dr. Anindita

Authors

Dr. Ganapathi Dr. Vageesh Dr. Belinda Dr Sonali Appaiah, Dr. Anindita

Project Status

ongoing

Project Type

ESI